Accel Research Site - Achieve - Birmingham - ERN - PPDS

Birmingham, Alabama 35216

0 studies enrolling now · 3 studies all time

What they study most

Cytomegalovirus Infection, Respiratory Syncytial Virus, SARS-CoV-2 Infection

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed